Pages that link to "Q53021749"
Jump to navigation
Jump to search
The following pages link to New Method for Calculating the Intrinsic Absorption Rate of Drugs (Q53021749):
Displaying 50 items.
- Paracellular absorption: a bat breaks the mammal paradigm (Q28471926) (← links)
- Capacity for absorption of water-soluble secondary metabolites greater in birds than in rodents (Q28481315) (← links)
- Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects (Q30430396) (← links)
- In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers (Q30674700) (← links)
- Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships (Q31994932) (← links)
- Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures (Q31994954) (← links)
- Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam (Q33406712) (← links)
- Absorption and disposition kinetics of amoxicillin in normal human subjects (Q33723729) (← links)
- Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep (Q33923512) (← links)
- Absorption‐dependent apparent volume of distribution at steady state (Vss/F) in pharmacokinetic data analysis (Q34015139) (← links)
- Pharmacokinetic characterisation of transdermal delivery systems (Q34060648) (← links)
- Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent (Q34282376) (← links)
- Bioavailability and absorption kinetics of nicotine following application of a transdermal system (Q34345727) (← links)
- Oral absorption of CGS-20625, an insoluble drug, in dogs and man. (Q34372953) (← links)
- Cyclosporin-erythromycin interaction in renal transplant patients (Q34397060) (← links)
- Metformin kinetics in healthy subjects and in patients with diabetes mellitus (Q34449285) (← links)
- Absorption and bioavailability of oral erythromycin (Q34449349) (← links)
- Fate of [14C]-bumetanide in man (Q34515570) (← links)
- Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin (Q34622703) (← links)
- Paracellular absorption is relatively low in the herbivorous Egyptian spiny-tailed lizard, Uromastyx aegyptia (Q34676367) (← links)
- pH-related changes in the absorption of dipyridamole in the elderly (Q34724447) (← links)
- Bioavailability of drugs: the digoxin dilemma (Q34725382) (← links)
- Absorption of pivampicillin in postoperative patients (Q34933993) (← links)
- Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans (Q34979027) (← links)
- Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development (Q35153417) (← links)
- Heterogeneity of inhibitory mechanisms in the nucleus accumbens and preoptic area of the [proceedings] (Q35176460) (← links)
- Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers (Q35640637) (← links)
- Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability (Q35825164) (← links)
- Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications (Q35981423) (← links)
- Bioavailability Determination of Two Crystal Forms of Sulfameter in Humans from Urinary Excretion Data (Q36532955) (← links)
- Properties of the recirculation model: Calculation of the amount of drug in the body from blood concentration data, with application to absorption rate calculations (Q36658943) (← links)
- Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlations (Q36765405) (← links)
- Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies (Q37713707) (← links)
- Digestive physiology: a view from molecules to ecosystem (Q37886479) (← links)
- An update on computational oral absorption simulation (Q37937047) (← links)
- Pharmacokinetic characterization of controlled-release formulations (Q37946835) (← links)
- Pharmacokinetics of non-intravenous formulations of fentanyl (Q38055713) (← links)
- An overview of preparation and evaluation sustained-release injectable microspheres (Q38058839) (← links)
- In vitro-in vivo correlations: general concepts, methodologies and regulatory applications (Q38541574) (← links)
- Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system (Q38583336) (← links)
- An inequality-constrained least-squares deconvolution method (Q38698369) (← links)
- The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II). (Q38730326) (← links)
- Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II). (Q38738922) (← links)
- Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions (Q38790679) (← links)
- Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug Applications (Q38915187) (← links)
- A model independent method for estimating the in vivo release rate constant of a drug from its oral formulations (Q39104083) (← links)
- The effects of some sweetening agents and osmotic pressure on the intestinal absorption of sulfafurazole in the rat (Q39283025) (← links)
- Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. (Q39478947) (← links)
- The bioavailability, dispostion kinetics and dosage of sulphadimethoxine in dogs (Q39528573) (← links)
- System approaches in pharmacokinetics: I. Basic concepts (Q39634069) (← links)